Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LillyDirect Foundayo vs Measured

LillyDirect Foundayo
Graded #173

Lower grade

vs+7.8999999999999915
Measured
Graded #58

Higher grade

The verdict

Measured takes it — 75.1/100 to 67.2/100.

Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMeasured +14
72
86
Dose & formulationMeasured +18
59
77
Clinical oversightMeasured +9
78
87
Labs & monitoringMeasured +11
52
63
FulfillmentLillyDirect Foundayo +13
80
67
Contract termsLillyDirect Foundayo +14
55
41
LillyDirect Foundayo · left barMeasured · right bar

The numbers

MetricLillyDirect FoundayoMeasured
WeighScore67.2/10075.1/100
GradeCC
Scorecard rank#173#58
SemaglutideNot disclosed$119/mo (compounded)
TirzepatideNot disclosed$229/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow
Measured

Graded #58 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • Membership ($49/mo) is billed separately on top of medication cost
  • Compounded medications are not FDA-approved
  • Compounding/dispensing pharmacies not individually named
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard